NQO1 and non-small cell lung carcinoma: In cisplatin-resistant non-small cell lung cancer, the utilization of the NQO1 substrate, 2-methoxy-6-acetyl-7-methyljuglone, induced ferroptosis and offered a potential avenue to circumvent chemoresistance [44].